Authors: Joyce, RM Kraser, CN Tetrealt, JC Giallombardo, N McDermott, D Levine, J Umiel, T Regan, M Hurley, D Uhl, L Avigan, D

Citation: Rm. Joyce et al., Rituximab and ifosfamide, mitoxantrone, etoposide (RIME) with Neupogen (R)support for B-cell non-Hodgkin's lymphoma prior to high-dose chemotherapy with autologous haematopoietic transplant, EUR J HAEMA, 66, 2001, pp. 56-62

Authors: Blackall, DP Uhl, L Spitalnik, SL

Citation: Dp. Blackall et al., Cryoprecipitate-reduced plasma: rationale for use and efficacy in the treatment of thrombotic thrombocytopenic purpura, TRANSFUSION, 41(6), 2001, pp. 840-844

Authors: Perkins, J Kaminer, L Kruskall, M Cannon, M Uhl, L Dzik, W Silver, H O'Neill, M Popovsky, M King, K Ness, P AuBuchon, J Shapiro, A Yomtovian, R Petz, LD

Citation: J. Perkins et al., Should the FDA mandate that autologous units drawn and transfused within asingle institution be tested for markers of infectious disease?, TRANSFUSION, 40(6), 2000, pp. 752-754